Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-072519
Filing Date
2026-02-26
Accepted
2026-02-25 19:22:59
Documents
98
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acad-20251231.htm   iXBRL 10-K 3941024
2 EX-10.25 acad-ex10_25.htm EX-10.25 184134
3 EX-10.52 acad-ex10_52.htm EX-10.52 471269
4 EX-10.53 acad-ex10_53.htm EX-10.53 441628
5 EX-21.1 acad-ex21_1.htm EX-21.1 17797
6 EX-23.1 acad-ex23_1.htm EX-23.1 12669
7 EX-31.1 acad-ex31_1.htm EX-31.1 14696
8 EX-31.2 acad-ex31_2.htm EX-31.2 14259
9 EX-32.1 acad-ex32_1.htm EX-32.1 8103
10 EX-32.2 acad-ex32_2.htm EX-32.2 7932
11 GRAPHIC img76302267_0.jpg GRAPHIC 440660
12 GRAPHIC img76302267_1.jpg GRAPHIC 134385
  Complete submission text file 0001193125-26-072519.txt   19407292

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20251231.xsd EX-101.SCH 1994194
101 EXTRACTED XBRL INSTANCE DOCUMENT acad-20251231_htm.xml XML 3666860
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 26681011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)